{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:29:34Z","timestamp":1793276974962,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI116868, R01 AI181659, R56 AI138810"],"award-info":[{"award-number":["R01 AI116868, R01 AI181659, R56 AI138810"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI116868, R01 AI181659, R56 AI138810"],"award-info":[{"award-number":["R01 AI116868, R01 AI181659, R56 AI138810"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00755-y","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T03:23:36Z","timestamp":1759893816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Integrated HBV DNA in the Quest for a Cure in HIV\/HBV co-infection"],"prefix":"10.1007","volume":"22","author":[{"given":"Monika","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe L.","family":"Thio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Balagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"755_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Fact sheet 2023. Latest global and regional statistics on the status of the AIDS epidemic. 2021."},{"key":"755_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"Y-C Hsu","year":"2023","unstructured":"Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20:524\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"755_CR3","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/cid\/ciz1170","volume":"71","author":"S Leumi","year":"2020","unstructured":"Leumi S, Bigna JJ, Amougou MA, Ngouo A, Nyaga UF, Noubiap JJ. Global burden of hepatitis B infection in people living with human immunodeficiency virus: a systematic review and meta-analysis. Clin Infect Dis. 2020;71:2799\u2013806.","journal-title":"Clin Infect Dis"},{"key":"755_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"PR Galle","year":"2018","unstructured":"Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul J-L, et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182\u2013236.","journal-title":"J Hepatol"},{"key":"755_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/infdis\/jir720","volume":"205","author":"HM Chun","year":"2012","unstructured":"Chun HM, Roediger MP, Hullsiek KH, Thio CL, Agan BK, Bradley WP, et al. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis. 2012;205:185\u201393.","journal-title":"J Infect Dis"},{"key":"755_CR6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/cid\/ciw531","volume":"63","author":"MB Klein","year":"2016","unstructured":"Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, et al. Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras. Clin Infect Dis. 2016;63:1160\u20137.","journal-title":"Clin Infect Dis"},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1056\/NEJMoa067710","volume":"356","author":"MA McMahon","year":"2007","unstructured":"McMahon MA, Jilek BL, Brennan TP, Shen L, Zhou Y, Wind-Rotolo M, et al. The HBV drug entecavir\u2014effects on HIV-1 replication and resistance. N Engl J Med. 2007;356:2614\u201321.","journal-title":"N Engl J Med"},{"key":"755_CR8","first-page":"35","volume":"21","author":"S Sun","year":"2021","unstructured":"Sun S, Yang Q, Sheng Y, Fu Y, Sun C, Deng C. Investigational drugs with dual activity against HBV and HIV (review). Exp Ther Med. 2021;21:35.","journal-title":"Exp Ther Med"},{"key":"755_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","volume":"134","author":"M Nassal","year":"2008","unstructured":"Nassal M, Hepatitis B. Hepatitis B. viruses: Reverse transcription a different way. Virus Res. 2008;134:235\u201349.","journal-title":"Virus Res."},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jmb.2007.04.057","volume":"370","author":"KM Haines","year":"2007","unstructured":"Haines KM, Loeb DD. The sequence of the RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J Mol Biol. 2007;370:471\u201380.","journal-title":"J Mol Biol"},{"key":"755_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/gutjnl-2014-308989","volume":"65","author":"X-L Zhao","year":"2016","unstructured":"Zhao X-L, Yang J-R, Lin S-Z, Ma H, Guo F, Yang R-F, et al. Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV. Gut. 2016;65:502\u201311.","journal-title":"Gut"},{"key":"755_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2008.12.003","volume":"286","author":"I Chemin","year":"2009","unstructured":"Chemin I, Zoulim F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett. 2009;286:52\u20139.","journal-title":"Cancer Lett"},{"key":"755_CR13","doi-asserted-by":"publisher","first-page":"11135","DOI":"10.1073\/pnas.0403925101","volume":"101","author":"CA Bill","year":"2004","unstructured":"Bill CA, Summers J. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci U S A. 2004;101:11135\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"755_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02007-17","volume":"92","author":"T Tu","year":"2018","unstructured":"Tu T, Budzinska MA, Vondran FWR, Shackel NA, Urban S. Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles. J Virol. 2018;92:e02007\u201317.","journal-title":"J Virol"},{"key":"755_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","volume":"110","author":"ARW Schr\u00f6der","year":"2002","unstructured":"Schr\u00f6der ARW, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521\u20139.","journal-title":"Cell"},{"key":"755_CR16","doi-asserted-by":"publisher","DOI":"10.1201\/9780429448362","volume-title":"Human molecular genetics","author":"T Strachan","year":"2018","unstructured":"Strachan T. Human molecular genetics. 4th ed. New York: Garland Science; 2018.","edition":"4"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/jmv.25227","volume":"90","author":"SB Larsson","year":"2018","unstructured":"Larsson SB, Tripodi G, Raimondo G, Saitta C, Norkrans G, Pollicino T, et al. Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. J Med Virol. 2018;90:1568\u201375.","journal-title":"J Med Virol"},{"key":"755_CR18","doi-asserted-by":"crossref","unstructured":"Ramirez R, van Buuren N, Gamelin L, Soulette C, May L, Han D et al. Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines. J Virol. 2021;95:e00299-21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8428387\/","DOI":"10.1128\/JVI.00299-21"},{"key":"755_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100449","volume":"4","author":"N van Buuren","year":"2022","unstructured":"van Buuren N, Ramirez R, Soulette C, Suri V, Han D, May L, et al. Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B. JHEP Rep. 2022;4:100449.","journal-title":"JHEP Rep"},{"key":"755_CR20","unstructured":"Schneller D, Angel P. Cellular Origin of Hepatocellular Carcinoma. In: Tirnitz-Parker JEE, editor. Hepatocellular Carcinoma [Internet]. Brisbane (AU): Codon Publications; 2019. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549196\/"},{"key":"755_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/jvh.13356","volume":"27","author":"J Ringlander","year":"2020","unstructured":"Ringlander J, Skoglund C, Prakash K, Andersson ME, Larsson SB, Tang K-W, et al. Deep sequencing of liver explant transcriptomes reveals extensive expression from integrated hepatitis B virus DNA. J Viral Hepat. 2020;27:1162\u201370.","journal-title":"J Viral Hepat"},{"key":"755_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/jvh.12380","volume":"22","author":"T Tu","year":"2015","unstructured":"Tu T, Mason WS, Clouston AD, Shackel NA, McCaughan GW, Yeh MM, et al. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection. J Viral Hepat. 2015;22:737\u201353. https:\/\/doi.org\/10.1111\/jvh.12380.","journal-title":"J Viral Hepat"},{"key":"755_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/genes9070365","volume":"9","author":"MA Budzinska","year":"2018","unstructured":"Budzinska MA, Shackel NA, Urban S, Tu T. Cellular genomic sites of hepatitis B virus DNA integration. Genes. 2018;9:365.","journal-title":"Genes"},{"key":"755_CR24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","volume":"151","author":"WS Mason","year":"2016","unstructured":"Mason WS, Gill US, Litwin S, Zhou Y, Peri S, Pop O, et al. HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant. Gastroenterology. 2016;151:986\u201398.","journal-title":"Gastroenterology"},{"key":"755_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/carcin\/bgs406","volume":"34","author":"ST Toh","year":"2013","unstructured":"Toh ST, Jin Y, Liu L, Wang J, Babrzadeh F, Gharizadeh B, et al. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. Carcinogenesis. 2013;34:787\u201398.","journal-title":"Carcinogenesis"},{"key":"755_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"W-K Sung","year":"2012","unstructured":"Sung W-K, Zheng H, Li S, Chen R, Liu X, Li Y, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44:765\u20139.","journal-title":"Nat Genet"},{"key":"755_CR27","doi-asserted-by":"crossref","unstructured":"Zhao L-H, Liu X, Yan H-X, Li W-Y, Zeng X, Yang Y et al. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun. 2016;7 :12992.","DOI":"10.1038\/ncomms12992"},{"key":"755_CR28","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.7150\/jca.26052","volume":"9","author":"L Yang","year":"2018","unstructured":"Yang L, Ye S, Zhao X, Ji L, Zhang Y, Zhou P, et al. Molecular characterization of HBV DNA integration in patients with hepatitis and hepatocellular carcinoma. J Cancer. 2018;9:3225\u201335.","journal-title":"J Cancer"},{"key":"755_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/hep.31231","volume":"73","author":"KM-F Sze","year":"2021","unstructured":"Sze KM-F, Ho DW-H, Chiu Y-T, Tsui Y-M, Chan L-K, Lee JM-F, et al. Hepatitis B Virus-Telomerase reverse transcriptase promoter integration harnesses host ELF4, resulting in telomerase reverse transcriptase gene transcription in hepatocellular carcinoma. Hepatol Baltim Md. 2021;73:23\u201340.","journal-title":"Hepatol Baltim Md"},{"key":"755_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000530699","volume":"13","author":"C-L Li","year":"2023","unstructured":"Li C-L, Hsu C-L, Lin Y-Y, Ho M-C, Hu, Chen C-L, et al. HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features. Liver Cancer. 2023;13:41\u201355. https:\/\/doi.org\/10.1159\/000530699.","journal-title":"Liver Cancer"},{"key":"755_CR31","doi-asserted-by":"publisher","first-page":"e1003065","DOI":"10.1371\/journal.pgen.1003065","volume":"8","author":"D Ding","year":"2012","unstructured":"Ding D, Lou X, Hua D, Yu W, Li L, Wang J, et al. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet. 2012;8:e1003065.","journal-title":"PLoS Genet"},{"key":"755_CR32","doi-asserted-by":"publisher","first-page":"B533","DOI":"10.1093\/gerona\/55.11.B533","volume":"55","author":"K Takubo","year":"2000","unstructured":"Takubo K, Nakamura K-I, Izumiyama N, Furugori E, Sawabe M, Arai T, et al. Telomere shortening with aging in human liver. J Gerontol Biol Sci Med Sci. 2000;55:B533\u20136.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"755_CR33","doi-asserted-by":"crossref","unstructured":"Dong H, Zhang L, Qian Z, Zhu X, Zhu G, Chen Y et al. Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma. PloS One. 2015;10:e0123175. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4406717\/","DOI":"10.1371\/journal.pone.0123175"},{"key":"755_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220376","volume":"14","author":"O Podlaha","year":"2019","unstructured":"Podlaha O, Wu G, Downie B, Ramamurthy R, Gaggar A, Subramanian M, et al. Genomic modeling of hepatitis B virus integration frequency in the human genome. PLoS One. 2019;14:e0220376. https:\/\/doi.org\/10.1371\/journal.pone.0220376.","journal-title":"PLoS One"},{"issue":"18","key":"755_CR35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161818","volume":"132","author":"T Grudda","year":"2022","unstructured":"Grudda T, Hwang HS, Taddese M, Quinn J, Sulkowski MS, Sterling RK, et al. Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment. J Clin Invest. 2022;132(18):e161818.","journal-title":"J Clin Invest"},{"key":"755_CR36","doi-asserted-by":"publisher","first-page":"eaan0241","DOI":"10.1126\/scitranslmed.aan0241","volume":"9","author":"CI Wooddell","year":"2017","unstructured":"Wooddell CI, Yuen M-F, Chan HL-Y, Gish RG, Locarnini SA, Chavez D, et al. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg. Sci Transl Med. 2017;9:eaan0241.","journal-title":"Sci Transl Med"},{"key":"755_CR37","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/infdis\/jiaa572","volume":"225","author":"GE Rydell","year":"2022","unstructured":"Rydell GE, Larsson SB, Prakash K, Andersson M, Norder H, Hellstrand K, et al. Abundance of noncircular intrahepatic hepatitis B virus DNA may reflect frequent integration into human DNA in chronically infected patients. J Infect Dis. 2022;225:1982\u201390.","journal-title":"J Infect Dis"},{"key":"755_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/gutjnl-2023-330577","volume":"73","author":"X Yu","year":"2024","unstructured":"Yu X, Gong Q, Yu D, Chen Y, Jing Y, Zoulim F, et al. Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss. Gut. 2024;73:797\u2013809.","journal-title":"Gut"},{"issue":"6","key":"755_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI184243","volume":"135","author":"M Taddese","year":"2025","unstructured":"Taddese M, Grudda T, Belluccini G, Anderson M, Cloherty G, Hwang HS, et al. Transcription of hepatitis B surface antigen shifts from CccDNA to integrated HBV DNA during treatment. J Clin Invest. 2025;135(6):e184243.","journal-title":"J Clin Invest"},{"key":"755_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jhep.2006.05.014","volume":"45","author":"DK-H Wong","year":"2006","unstructured":"Wong DK-H, Yuen M-F, Poon RT-P, Yuen JC-H, Fung J, Lai C-L. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol. 2006;45:553\u20139.","journal-title":"J Hepatol"},{"key":"755_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/jmv.24601","volume":"89","author":"N Chuaypen","year":"2017","unstructured":"Chuaypen N, Sriprapun M, Praianantathavorn K, Payungporn S, Wisedopas N, Poovorawan Y, et al. Kinetics of serum HBsAg and intrahepatic CccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B. J Med Virol. 2017;89:130\u20138.","journal-title":"J Med Virol"},{"key":"755_CR42","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/infdis\/jiz607","volume":"221","author":"A Balagopal","year":"2020","unstructured":"Balagopal A, Hwang HS, Grudda T, Quinn J, Sterling RK, Sulkowski MS, et al. Single hepatocyte hepatitis B virus transcriptional landscape in HIV coinfection. J Infect Dis. 2020;221:1462\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiz607.","journal-title":"J Infect Dis"},{"key":"755_CR43","doi-asserted-by":"publisher","first-page":"e140584","DOI":"10.1172\/jci.insight.140584","volume":"5","author":"A Balagopal","year":"2020","unstructured":"Balagopal A, Grudda T, Ribeiro RM, Saad YS, Hwang HS, Quinn J, et al. Single hepatocytes show persistence and transcriptional inactivity of hepatitis B. JCI Insight. 2020;5:e140584.","journal-title":"JCI Insight"},{"key":"755_CR44","doi-asserted-by":"publisher","first-page":"e0290889","DOI":"10.1371\/journal.pone.0290889","volume":"18","author":"J Kim","year":"2023","unstructured":"Kim J, Newcomb CW, Carbonari D, Torgersen J, Althoff KN, Kitahata MM, et al. Hepatitis B care cascade among people with HIV\/HBV coinfection in the North American AIDS cohort collaboration on research and design, 2012\u20132016. PLoS ONE. 2023;18:e0290889.","journal-title":"PLoS ONE"},{"key":"755_CR45","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jhep.2021.04.051","volume":"75","author":"M-A Meier","year":"2021","unstructured":"Meier M-A, Calabrese D, Suslov A, Terracciano LM, Heim MH, Wieland S. Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load. J Hepatol. 2021;75:840\u20137.","journal-title":"J Hepatol"},{"key":"755_CR46","doi-asserted-by":"publisher","first-page":"e0171722","DOI":"10.1128\/jvi.01717-22","volume":"97","author":"B Peng","year":"2023","unstructured":"Peng B, Jing Z, Zhou Z, Sun Y, Guo G, Tan Z, et al. Nonproductive hepatitis B virus covalently closed circular DNA generates HBx-related transcripts from the hbx\/enhancer i region and acquires reactivation by superinfection in single cells. J Virol. 2023;97:e0171722.","journal-title":"J Virol"},{"key":"755_CR47","doi-asserted-by":"publisher","first-page":"e801","DOI":"10.1093\/cid\/ciac383","volume":"76","author":"N Chow","year":"2023","unstructured":"Chow N, Wong D, Lai C-L, Mak L-Y, Fung J, Ma H-T, et al. Effect of antiviral treatment on hepatitis B virus integration and hepatocyte clonal expansion. Clin Infect Dis Off Publ Infect Dis Soc Am. 2023;76:e801\u20139.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"755_CR48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/gutjnl-2024-332526","volume":"74","author":"DZ Pan","year":"2025","unstructured":"Pan DZ, Soulette CM, Aggarwal A, Han D, Van Buuren N, Wu P, et al. Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B. Gut. 2025;74:628\u201338. https:\/\/doi.org\/10.1136\/gutjnl-2024-332526.","journal-title":"Gut"},{"key":"755_CR49","doi-asserted-by":"crossref","unstructured":"Yuen M-F, Schiefke I, Yoon J-H, Ahn SH, Heo J, Kim JH et al. RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection. Hepatology. 2020;72:19. Available from: https:\/\/journals.lww.com\/hep\/fulltext\/2020\/07000\/rna_interference_therapy_with_arc_520_results_in.4.aspx","DOI":"10.1002\/hep.31008"},{"issue":"3","key":"755_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jhep.2024.03.046","volume":"81","author":"K Agarwal","year":"2024","unstructured":"Agarwal K, Buti M, van B\u00f6mmel F, Lampertico P, Janczewska E, Bourliere M, et al. JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: reef-2. J Hepatol. 2024;81(3):404\u201314.","journal-title":"J Hepatol"},{"key":"755_CR51","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1097\/QAD.0b013e32831103ad","volume":"22","author":"GM Clifford","year":"2008","unstructured":"Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS. 2008;22:2135\u201341.","journal-title":"AIDS"},{"key":"755_CR52","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/hep.510290447","volume":"29","author":"J Colin","year":"1999","unstructured":"Colin J, Cazals-Hatem D, Loriot MA, Martinot\u2010Peignoux M, Pham BN, Auperin A, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999;29:1306\u201310.","journal-title":"Hepatology"},{"key":"755_CR53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00002030-199705000-00007","volume":"11","author":"RJ Gilson","year":"1997","unstructured":"Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS. 1997;11:597\u2013606.","journal-title":"AIDS"},{"key":"755_CR54","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.31839","volume":"74","author":"HN Kim","year":"2021","unstructured":"Kim HN, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, et al. Risk of HCC with hepatitis B viremia among HIV\/HBV-coinfected persons in North America. Hepatology. 2021;74:1190\u2013202.","journal-title":"Hepatology"},{"key":"755_CR55","doi-asserted-by":"publisher","first-page":"7649","DOI":"10.1128\/JVI.00183-09","volume":"83","author":"JJ Chang","year":"2009","unstructured":"Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJV, Revill P, Iser D, et al. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. J Virol. 2009;83:7649\u201358.","journal-title":"J Virol"},{"key":"755_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152043","volume":"11","author":"G Wandeler","year":"2016","unstructured":"Wandeler G, Musukuma K, Z\u00fcrcher S, Vinikoor MJ, Llenas-Garc\u00eda J, Aly MM, et al. Hepatitis B infection, viral load and resistance in HIV-infected patients in Mozambique and Zambia. PLoS One. 2016;11:e0152043.","journal-title":"PLoS One"},{"key":"755_CR57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.32352","volume":"76","author":"R Erken","year":"2022","unstructured":"Erken R, Loukachov V, van Dort K, van den Hurk A, Takkenberg RB, de Niet A, et al. Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B. Hepatology. 2022;76:196\u2013206. https:\/\/doi.org\/10.1002\/hep.32352.","journal-title":"Hepatology"},{"key":"755_CR58","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.4161\/hv.25813","volume":"9","author":"M Isaguliants","year":"2013","unstructured":"Isaguliants M, Smirnova O, Ivanov AV, Kilpelainen A, Kuzmenko Y, Petkov S, et al. Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme\u2019s performance in gene immunization. Hum Vaccines Immunother. 2013;(9):2111\u20139.","journal-title":"Hum Vaccines Immunother"},{"key":"755_CR59","doi-asserted-by":"publisher","first-page":"e65126","DOI":"10.1371\/journal.pone.0065126","volume":"8","author":"G Teto","year":"2013","unstructured":"Teto G, Kanmogne GD, Torimiro JN, Alemnji G, Nguemaim FN, Takou D, et al. Lipid peroxidation and total cholesterol in HAART-na\u00efve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon. PLoS One. 2013;8:e65126.","journal-title":"PLoS One"},{"key":"755_CR60","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.bbih.2021.100235","volume":"13","author":"S Buckley","year":"2021","unstructured":"Buckley S, Byrnes S, Cochrane C, Roche M, Estes JD, Selemidis S, et al. The role of oxidative stress in HIV-associated neurocognitive disorders. Brain Behav Immun - Health. 2021;13:100235.","journal-title":"Brain Behav Immun - Health"},{"key":"755_CR61","doi-asserted-by":"publisher","first-page":"e0150961","DOI":"10.1371\/journal.pone.0150961","volume":"11","author":"J-H Ren","year":"2016","unstructured":"Ren J-H, Chen X, Zhou L, Tao N-N, Zhou H-Z, Liu B, et al. Protective role of Sirtuin3 (SIRT3) in oxidative stress mediated by hepatitis B virus X protein expression. PLoS One. 2016;11:e0150961.","journal-title":"PLoS One"},{"key":"755_CR62","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jhep.2024.01.026","volume":"80","author":"M Xu","year":"2024","unstructured":"Xu M, Warner C, Duan X, Cheng Z, Jeyarajan AJ, Li W, et al. HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1\u03b1- and TGF-\u03b21-dependent pathway. J Hepatol. 2024;80:868\u201381.","journal-title":"J Hepatol"},{"key":"755_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00757-18","volume":"9","author":"G Duette","year":"2018","unstructured":"Duette G, Pereyra Gerber P, Rubione J, Perez PS, Landay AL, Crowe SM, et al. Induction of HIF-1\u03b1 by HIV-1 infection in CD4\u2009+\u2009T cells promotes viral replication and drives extracellular vesicle-mediated inflammation. MBio. 2018;9:10\u20131128.","journal-title":"MBio"},{"key":"755_CR64","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/hep.31902","volume":"74","author":"T Riedl","year":"2021","unstructured":"Riedl T, Faure-Dupuy S, Rolland M, Schuehle S, Hizir Z, Calderazzo S, et al. Hypoxia\u2010inducible factor 1 alpha\u2013mediated RelB\/APOBEC3B down\u2010regulation allows hepatitis B virus persistence. Hepatology. 2021;74:1766\u201381.","journal-title":"Hepatology"},{"key":"755_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhep.2020.12.034","volume":"75","author":"PAC Wing","year":"2021","unstructured":"Wing PAC, Liu PJ, Harris JM, Magri A, Michler T, Zhuang X, et al. Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter. J Hepatol. 2021;75:64\u201373.","journal-title":"J Hepatol"},{"key":"755_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1381826","volume":"15","author":"M Xia","year":"2025","unstructured":"Xia M, Zhao Y, Yu T, Lin X, Liao G, Jiang Y, et al. Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV\/HBV coinfection after combined antiretroviral therapy. Front Cell Infect Microbiol. 2025;15:1381826. https:\/\/doi.org\/10.3389\/fcimb.2025.1381826.","journal-title":"Front Cell Infect Microbiol"},{"key":"755_CR67","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1053\/j.gastro.2010.08.045","volume":"139","author":"TE de Vries\u2013Sluijs","year":"2010","unstructured":"de Vries\u2013Sluijs TE, Reijnders JG, Hansen BE, Zaaijer HL, Prins JM, Pas SD, et al. Long-term therapy with Tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology. 2010;139:1934\u201341.","journal-title":"Gastroenterology"},{"key":"755_CR68","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000002386","volume":"84","author":"J Audsley","year":"1999","unstructured":"Audsley J, Avihingsanon A, Littlejohn M, Bowden S, Matthews GV, Fairley CK, et al. Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure? J Acquir Immune Defic Syndr. 1999;84:527\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"755_CR69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S2468-1253(18)30308-X","volume":"4","author":"K Zhou","year":"2019","unstructured":"Zhou K, Contag C, Whitaker E, Terrault N. Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses. Lancet Gastroenterol Hepatol. 2019;4:227\u201338.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"755_CR70","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.24221","volume":"53","author":"JM Lee","year":"2011","unstructured":"Lee JM, Ahn SH, Kim HS, Park H, Chang HY, Kim DY, et al. Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. Hepatology. 2011;53:1486.","journal-title":"Hepatology"},{"key":"755_CR71","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/QAD.0b013e328352224d","volume":"26","author":"S Maylin","year":"2012","unstructured":"Maylin S, Boyd A, Lavocat F, Gozlan J, Lascoux-Combe C, Miailhes P, et al. Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients. AIDS. 2012;26:939\u201349.","journal-title":"AIDS"},{"key":"755_CR72","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jvh.12175","volume":"21","author":"R Strassl","year":"2014","unstructured":"Strassl R, Reiberger T, Honsig C, Payer BA, Mandorfer M, Grabmeier-Pfistershammer K, et al. Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-\/HBV-coinfected patients. J Viral Hepat. 2014;21:508\u201316.","journal-title":"J Viral Hepat"},{"key":"755_CR73","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/infdis\/jiz450","volume":"221","author":"BV Chihota","year":"2020","unstructured":"Chihota BV, Wandeler G, Chilengi R, Mulenga L, Chung RT, Bhattacharya D, et al. High rates of hepatitis B virus (HBV) functional cure among human immunodeficiency virus-HBV coinfected patients on antiretroviral therapy in Zambia. J Infect Dis. 2020;221:218\u201322.","journal-title":"J Infect Dis"},{"key":"755_CR74","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/520752","volume":"45","author":"P Miailhes","year":"2007","unstructured":"Miailhes P, Trabaud M-A, Pradat P, Lebouch\u00e9 B, le Chevallier M, Chevallier P, et al. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis. 2007;45:624\u201332.","journal-title":"Clin Infect Dis"},{"key":"755_CR75","doi-asserted-by":"publisher","first-page":"e1006285","DOI":"10.1371\/journal.ppat.1006285","volume":"13","author":"RT Gandhi","year":"2017","unstructured":"Gandhi RT, McMahon DK, Bosch RJ, Lalama CM, Cyktor JC, Macatangay BJ, et al. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. PLoS Pathog. 2017;13:e1006285.","journal-title":"PLoS Pathog"},{"key":"755_CR76","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1038\/s41591-023-02611-1","volume":"29","author":"A Mohammadi","year":"2023","unstructured":"Mohammadi A, Etemad B, Zhang X, Li Y, Bedwell GJ, Sharaf R, et al. Viral and host mediators of non-suppressible HIV-1 viremia. Nat Med. 2023;29:3212\u201323.","journal-title":"Nat Med"},{"key":"755_CR77","doi-asserted-by":"crossref","unstructured":"Balagopal A, Gupte N, Shivakoti R, Cox AL, Yang W-T, Berendes S, et al. Continued elevation of interleukin-18 and interferon-\u03b3 after initiation of antiretroviral therapy and clinical failure in a diverse multicountry human immunodeficiency virus cohort. Oxford University Press; 2016. p. ofw118.","DOI":"10.1093\/ofid\/ofw118"},{"key":"755_CR78","doi-asserted-by":"crossref","unstructured":"Sachithanandham J, Leep-Lazar J, Quinn J, Bowden K, Balasubramaniam P, Ward K, et al. Direct-Acting Antivirals Quickly Eradicate Hepatitis C Virus From the Liver in People With HumanImmunodeficiency Virus but Do Not Fully Reverse Immune Activation. J Infect Dis. 2025;231:1299\u2013308.","DOI":"10.1093\/infdis\/jiae598"},{"key":"755_CR79","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.01777-20","volume":"95","author":"S Sugawara","year":"2021","unstructured":"Sugawara S, El-Diwany R, Cohen LK, Rousseau KE, Williams CY, Veenhuis RT, et al. People with HIV-1 demonstrate type 1 interferon refractoriness associated with upregulated USP18. J Virol. 2021;95:10\u20131128.","journal-title":"J Virol"},{"key":"755_CR80","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","volume":"67","author":"L Allweiss","year":"2018","unstructured":"Allweiss L, Volz T, Giersch K, Kah J, Raffa G, Petersen J, et al. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo. Gut. 2018;67:542\u201352.","journal-title":"Gut"},{"key":"755_CR81","doi-asserted-by":"publisher","first-page":"11652","DOI":"10.1073\/pnas.1635109100","volume":"100","author":"J Summers","year":"2003","unstructured":"Summers J, Jilbert AR, Yang W, Aldrich CE, Saputelli J, Litwin S, et al. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci U S A. 2003;100:11652\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"755_CR82","doi-asserted-by":"publisher","DOI":"10.1242\/bio.029785","volume":"7","author":"RS Dagur","year":"2018","unstructured":"Dagur RS, Wang W, Cheng Y, Makarov E, Ganesan M, Suemizu H, et al. Human hepatocyte depletion in the presence of HIV-1 infection in dual reconstituted humanized mice. Biol Open. 2018;7:bio029785.","journal-title":"Biol Open"},{"key":"755_CR83","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7326\/M14-2768","volume":"163","author":"MJ Silverberg","year":"2015","unstructured":"Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D\u2019Souza G, et al. Cumulative incidence of cancer among persons with HIV in North america: A cohort study. Ann Intern Med. 2015;163:507\u201318.","journal-title":"Ann Intern Med"},{"key":"755_CR84","first-page":"349","volume":"30","author":"R Lombardi","year":"2017","unstructured":"Lombardi R, Lever R, Smith C, Marshall N, Rodger A, Bhagani S, et al. Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers. Ann Gastroenterol. 2017;30:349\u201356.","journal-title":"Ann Gastroenterol"},{"key":"755_CR85","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/hep.22665","volume":"49","author":"P Ingiliz","year":"2009","unstructured":"Ingiliz P, Valantin M, Duvivier C, Medja F, Dominguez S, Charlotte F, et al. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono\u2010infected patients on antiretroviral therapy. Hepatology. 2009;49:436\u201342.","journal-title":"Hepatology"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00755-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00755-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00755-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:57Z","timestamp":1769609037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00755-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00755-y","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"48"}}